Neuromuscular blockade management for intraoperative neural monitoring
This article reviews the literature on development of neuromuscular blockade management in thyroid surgery with intraoperative neural monitoring (IONM) in the past decade.
I‐Cheng Lu +2 more
doaj +2 more sources
Anesthetic Consideration of Patient With Myotonic Dystrophy Type 1: A Case Report and Review of Literature. [PDF]
ABSTRACT Myotonic dystrophy type 1 (DM1) presents significant anesthetic challenges. A 46‐year‐old woman with DM1 underwent emergent exploratory laparotomy. This case highlights the importance of conservative neuromuscular blocker dosing, quantitative neuromuscular monitoring, clinically‐guided timing of sugammadex administration, careful airway ...
Lin YC +7 more
europepmc +2 more sources
Remimazolam-Based Anesthesia Without Neuromuscular Blockade for Laparoscopic Surgery in a Patient With Immune-Mediated Necrotizing Myopathy: A Case Report. [PDF]
Background Immune‐mediated necrotizing myopathy causes progressive muscle weakness and may complicate anesthetic management because responses to neuromuscular blocking agents may be unpredictable and residual blockade may further compromise respiratory function. We report a case in which laparoscopic surgery was completed without neuromuscular blocking
Kobayashi Y, Wakabayashi R, Uchida K.
europepmc +2 more sources
Neuromuscular blocking agents and reversal agents
The neuromuscular blocking agents in routine clinical use may be classed as depolarizing or nondepolarizing. Suxamethonium is the only example of the depolarizing group and is an agonist at the neuromuscular receptor.
Pollard, Brian J.
core +9 more sources
Anesthetic Management of a Patient With Hereditary Spastic Paraplegia: A Case Report. [PDF]
Background Hereditary spastic paraplegia is an extremely rare, heterogenous, inherited, progressive neurologic disorder characterized by lower‐extremity weakness and spasticity in pure forms, with complex forms including symptoms such as seizures, dementia, and ataxia.
Sotelo I, Olsen KR.
europepmc +2 more sources
Delayed Recovery After General Anesthesia due to Undiagnosed Pseudocholinesterase Deficiency: A Case Report. [PDF]
Pseudocholinesterase deficiency is a rare pharmacogenetic disorder caused by a defect in the enzyme butyrylcholinesterase, which may result in delayed recovery following exposure to neuromuscular blocking agents such as succinylcholine and mivacurium.
Tzoneva Tobova D +3 more
europepmc +2 more sources
Lightning Strikes Twice in the Same Place: Mitochondrial Myopathy and Malignant Hyperthermia-A Case Report. [PDF]
Mitochondrial disease predominantly affects tissues reliant on aerobic metabolism, with an incidence of 1 in 4000 individuals and a broad spectrum of clinical presentations. Malignant hyperthermia is a pharmacogenetic disease in which a hypermetabolic reaction is triggered in malignant hyperthermia‐susceptible patients by specific anesthetic agents. We
de Melo RSES +9 more
europepmc +2 more sources
Farmacocinética y farmacodinamia del bromuro de rocuronio: Influencia de la terapia crónica con fenitoína. [PDF]
[spa] ANTECEDENTES: La administración crónica de fármacos antiepilépticos disminuye la intensidad del efecto de los fármacos bloqueantes neuromusculares (BNM), aunque existe cierta discrepancia a la hora de explicar si esta interacción se produce a nivel
Fernández Candil, Juan Luís
core +6 more sources
Noncardiogenic Pulmonary Edema After Neostigmine Administration During Emergence From General Anesthesia: A Case Report. [PDF]
We report the case of a previously healthy 27‐year‐old man who developed acute pulmonary edema shortly after receiving neostigmine‐atropine for neuromuscular blockade reversal during appendectomy under general anesthesia. Before extubation, he developed severe hypoxemia, increased airway pressures, pink frothy tracheal secretions, and bilateral diffuse
Stephan JC +3 more
europepmc +2 more sources
Resistance to non-depolarizing neuromuscular blocking agents [PDF]
The authors experienced three cases of the resistance to the nondepolarizing neuromuscular blocking agents (NMBAs), rocuronium. There are many factors that affect NMBAs such as steroid, endocrine or autoimmune diseases which are thyroid disease ...
Dong-Min Hyun +4 more
core +1 more source

